Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
PhilipV Peplow, Bridget Martinez
Neural Regeneration Research (2018) Vol. 14, Iss. 2, pp. 242-242
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Neuroinflammation as a Common Feature of Neurodegenerative Disorders
Leonardo Guzmán‐Martínez, Ricardo B. Maccioni, Víctor Andrade, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 597
Advances in the development of new biomarkers for Alzheimer’s disease
Timofey O. Klyucherev, Pawel K. Olszewski, Alena A. Shalimova, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 161
MicroRNAs and Cardiovascular Disease Risk
Charles Searles
Current Cardiology Reports (2024) Vol. 26, Iss. 2, pp. 51-60
Open Access | Times Cited: 26
MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
Francesco Angelucci, Kateřina Čechová, Martin Vališ, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 128
Long Noncoding RNA NEAT1 Aggravates Aβ-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease
Sha Ke, Zhaohui Yang, Fei Yang, et al.
Yonsei Medical Journal (2019) Vol. 60, Iss. 7, pp. 640-640
Open Access | Times Cited: 109
Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer’s disease
Aidan Kenny, Eva M. Jiménez‐Mateos, María Ascensión Zea‐Sevilla, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 96
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Hannah Walgrave, Lujia Zhou, Bart De Strooper, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 91
Efficiency of Traditional Chinese medicine targeting the Nrf2/HO-1 signaling pathway
Bin Li, Moussa Ide Nasser, Muqaddas Masood, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 126, pp. 110074-110074
Open Access | Times Cited: 76
The neurobiology of non-coding RNAs and Alzheimer’s disease pathogenesis: Pathways, mechanisms and translational opportunities
Elisabetta Lauretti, Konrad Dabrowski, Domenico Praticò
Ageing Research Reviews (2021) Vol. 71, pp. 101425-101425
Open Access | Times Cited: 74
Research progress on the role of extracellular vesicles in neurodegenerative diseases
Zhengzhe Li, Xiaoling Wang, Xiaoxing Wang, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics
Chunhui Guo, You Yanqiu, Jibing Chen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1
Pengxiang Li, Ying Xu, Baiping Wang, et al.
Journal of the Neurological Sciences (2020) Vol. 413, pp. 116793-116793
Closed Access | Times Cited: 63
Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach
Negar Sadat Soleimani Zakeri, Saeid Pashazadeh, Habib MotieGhader
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 61
Non-coding RNAs: Emerging from the discovery to therapeutic applications
Bruno Baptista, Micaela Riscado, João A. Queiroz, et al.
Biochemical Pharmacology (2021) Vol. 189, pp. 114469-114469
Closed Access | Times Cited: 44
Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer’s Disease
Caterina Visconte, Chiara Fenoglio, María Serpente, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14749-14749
Open Access | Times Cited: 20
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
Néha Datta, Charlotte Johnson, Dina Kao, et al.
Pharmacological Research (2023) Vol. 194, pp. 106870-106870
Open Access | Times Cited: 19
Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer’s Disease
Devyani Bhatnagar, Shreya Ladhe, Dileep Kumar
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 5954-5974
Closed Access | Times Cited: 17
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
Ming Zhang, Wei Han, Yuhao Xu, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 269-275
Open Access | Times Cited: 40
Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets
Omid Vakili, Pooria Asili, Zeinab Babaei, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 9, pp. 1335-1354
Closed Access | Times Cited: 24
miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease
Hyunjun Park, Yeong‐Bae Lee, Keun‐A Chang
International Journal of Biological Sciences (2022) Vol. 18, Iss. 5, pp. 2220-2234
Open Access | Times Cited: 23
miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells
Nan Zhang, Weiwei Li, Chunmei Lv, et al.
Neuroreport (2019) Vol. 31, Iss. 3, pp. 205-212
Closed Access | Times Cited: 40
MicroRNA-Mediated Control of Inflammation and Tolerance in Pregnancy
Ranjith Kamity, Surendra Sharma, Nazeeh Hanna
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 38
Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer’s Disease and Involvement of Neuroinflammation
Dandan Liu, Dandan Zhao, Yingkai Zhao, et al.
Current Alzheimer Research (2019) Vol. 16, Iss. 6, pp. 473-482
Closed Access | Times Cited: 38
Neuronal Development-Related miRNAs as Biomarkers for Alzheimer's Disease, Depression, Schizophrenia and Ionizing Radiation Exposure
Renu Chandra Segaran, Li Yun Chan, Hong Wang, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 1, pp. 19-52
Closed Access | Times Cited: 37
MicroRNA miR-212 regulates PDCD4 to attenuate Aβ25–35-induced neurotoxicity via PI3K/AKT signaling pathway in Alzheimer’s disease
Yanjun Wang, Qing Chang
Biotechnology Letters (2020) Vol. 42, Iss. 9, pp. 1789-1797
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top